Editing Seald

{{DISPLAYTITLE:Seald}}
{{Infobox company
| name = Seald AS
| org_number = 917997470
| founded = 2016-10-10
| employees = Not disclosed
| address = Norway
| industry = 72.100 – Biotechnology research
| website = https://www.seald.no
| nht_category = Startup
| description = Seald is developing an innovative approach to bile duct cancer (cholangiocarcinoma) therapeutics. An entirely new, innovative method to find a cure for bile duct cancer. Team includes board, management, advisory board, research partners, and investors.
| notes = No disclosed revenue or funding. Founded 2016. Bile duct cancer (cholangiocarcinoma) is an orphan disease with limited treatment options and high unmet need.
| related_companies = [[Hemispherian]], [[Exact Therapeutics]], [[Pharmasum Therapeutics]], [[Norway Health Tech]]
| categories = Norway Health Tech, Startups, Biotechnology, Oncology, Rare Disease
| sources = https://www.seald.no; https://data.brreg.no/enhetsregisteret/api/enheter/917997470
}}

== About ==

Seald AS is a Norwegian biotechnology company developing novel therapeutics for bile duct cancer (cholangiocarcinoma). Founded in 2016.

== Focus Area ==

Bile duct cancer (cholangiocarcinoma) is a rare but aggressive cancer arising from the bile ducts. It is classified as an orphan disease with limited treatment options, particularly for advanced/metastatic disease. The company is developing an entirely new, innovative approach to treating this cancer.

== Pipeline ==

Seald is developing:
* Technology platform for bile duct cancer
* Novel therapeutic candidates

== Organization ==

The company has a structured organization including:
* Board of Directors
* Management team
* Advisory Board
* Research partners
* Investor group

== Market ==

Cholangiocarcinoma (bile duct cancer) affects approximately 200,000 people globally per year. The 5-year survival rate for advanced disease is below 10%, representing significant unmet medical need. Targeted therapies and immunotherapies are active areas of development.

== References ==
<references/>

[[Category:Norway Health Tech]]
[[Category:Startups]]
[[Category:Biotechnology]]
[[Category:Oncology]]
[[Category:Rare Disease]]